JP2025107348A5 - - Google Patents
Info
- Publication number
- JP2025107348A5 JP2025107348A5 JP2025076681A JP2025076681A JP2025107348A5 JP 2025107348 A5 JP2025107348 A5 JP 2025107348A5 JP 2025076681 A JP2025076681 A JP 2025076681A JP 2025076681 A JP2025076681 A JP 2025076681A JP 2025107348 A5 JP2025107348 A5 JP 2025107348A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662415752P | 2016-11-01 | 2016-11-01 | |
| US62/415,752 | 2016-11-01 | ||
| JP2019522676A JP7291624B2 (ja) | 2016-11-01 | 2017-11-01 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
| JP2023091857A JP2023105046A (ja) | 2016-11-01 | 2023-06-02 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023091857A Division JP2023105046A (ja) | 2016-11-01 | 2023-06-02 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025107348A JP2025107348A (ja) | 2025-07-17 |
| JP2025107348A5 true JP2025107348A5 (enExample) | 2025-09-26 |
Family
ID=62076333
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522676A Active JP7291624B2 (ja) | 2016-11-01 | 2017-11-01 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
| JP2023091857A Withdrawn JP2023105046A (ja) | 2016-11-01 | 2023-06-02 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
| JP2025076681A Pending JP2025107348A (ja) | 2016-11-01 | 2025-05-02 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019522676A Active JP7291624B2 (ja) | 2016-11-01 | 2017-11-01 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
| JP2023091857A Withdrawn JP2023105046A (ja) | 2016-11-01 | 2023-06-02 | アルファ－ｖベータ－６インテグリンリガンド及びその使用 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US11180529B2 (enExample) |
| EP (2) | EP3981780A1 (enExample) |
| JP (3) | JP7291624B2 (enExample) |
| KR (1) | KR102634762B1 (enExample) |
| CN (2) | CN117285626A (enExample) |
| AU (2) | AU2017354041B2 (enExample) |
| CA (1) | CA3039618A1 (enExample) |
| DK (1) | DK3535397T3 (enExample) |
| EA (1) | EA201991102A1 (enExample) |
| ES (1) | ES2906109T3 (enExample) |
| HR (1) | HRP20220181T1 (enExample) |
| IL (2) | IL266343B2 (enExample) |
| JO (1) | JOP20190084B1 (enExample) |
| MX (3) | MX2019004909A (enExample) |
| PL (1) | PL3535397T3 (enExample) |
| SA (1) | SA519401709B1 (enExample) |
| SI (1) | SI3535397T1 (enExample) |
| TW (1) | TWI776821B (enExample) |
| WO (1) | WO2018085415A1 (enExample) |
| ZA (2) | ZA201901905B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018085415A1 (en) * | 2016-11-01 | 2018-05-11 | Arrowhead Pharmaceuticals, Inc. | Alpha-v beta-6 integrin ligands and uses thereof |
| AU2018227417B2 (en) | 2017-02-28 | 2021-12-23 | Morphic Therapeutic, Inc. | Inhibitors of (alpha-v)(beta-6) integrin |
| KR102605460B1 (ko) | 2017-02-28 | 2023-11-22 | 모픽 테라퓨틱, 인코포레이티드 | αvβ6 인테그린 억제제 |
| CN110832077B (zh) | 2017-07-06 | 2025-01-03 | 箭头药业股份有限公司 | 用于抑制α-ENaC表达的RNAi剂及使用方法 |
| EP3843727A4 (en) | 2018-08-29 | 2022-08-17 | Morphic Therapeutic, Inc. | INHIBITORS OF (ALPHA-V)(BETA-6) INTEGRIN |
| PT3844162T (pt) | 2018-08-29 | 2025-03-28 | Morphic Therapeutic Inc | Inibidores da integrina alfa v beta6 |
| TW202035400A (zh) | 2018-08-29 | 2020-10-01 | 美商莫菲克醫療股份有限公司 | 抑制αvβ6整合素 |
| KR102663798B1 (ko) | 2019-06-25 | 2024-05-03 | 주식회사 엘지에너지솔루션 | 배터리 시스템 |
| TW202130809A (zh) * | 2019-10-29 | 2021-08-16 | 美商愛羅海德製藥公司 | 用於抑制β-ENaC表現之RNAi藥劑、其組合物及使用方法 |
| KR20230066400A (ko) * | 2020-09-11 | 2023-05-15 | 애로우헤드 파마슈티컬스 인코포레이티드 | 인테그린 표적화 리간드 및 그의 용도 |
| TW202227627A (zh) | 2020-09-11 | 2022-07-16 | 美商愛羅海德製藥公司 | 用於抑制DUX4表現之RNAi藥劑、其組合物及使用方法 |
| CA3189071A1 (en) * | 2020-09-11 | 2022-03-17 | Xiaokai Li | Skeletal muscle delivery platforms and methods of use |
| IL301186A (en) * | 2020-09-11 | 2023-05-01 | Arrowhead Pharmaceuticals Inc | Skeletal muscle delivery platforms and methods of use |
| JP2024516096A (ja) | 2021-04-08 | 2024-04-12 | アローヘッド ファーマシューティカルズ インコーポレイテッド | 終末糖化産物受容体の発現を阻害するためのＲＮＡｉ剤、その組成物、及び使用方法 |
| KR20240014067A (ko) | 2021-05-28 | 2024-01-31 | 애로우헤드 파마슈티컬스 인코포레이티드 | 뮤신 5AC (MUC5AC)의 발현을 억제하기 위한 RNAi 작용제, 그의 조성물, 및 사용 방법 |
| EP4547683A2 (en) | 2022-06-30 | 2025-05-07 | Alnylam Pharmaceuticals, Inc. | Cyclic-disulfide modified phosphate based oligonucleotide prodrugs |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| DE19929410A1 (de) * | 1999-06-26 | 2000-12-28 | Merck Patent Gmbh | Inhibitoren des Integrins avß6 |
| CA2407086A1 (en) * | 2000-04-21 | 2001-11-01 | Amgen, Inc. | Integrin/adhesion antagonists |
| DE10118550A1 (de) * | 2001-04-14 | 2002-10-17 | Merck Patent Gmbh | Liganden des Integrins alpha¶nu¶beta¶6¶ |
| GB0520068D0 (en) * | 2005-10-03 | 2005-11-09 | Cancer Res Technology | av peptide ligand |
| MX2009001293A (es) | 2006-08-03 | 2009-02-11 | Astrazeneca Ab | Anticuerpos dirigidos a (v(6 y usos de los mismos. |
| AR066984A1 (es) | 2007-06-15 | 2009-09-23 | Novartis Ag | Inhibicion de la expresion de la subunidad alfa del canal epitelial de sodio (enac) por medio de arni (arn de interferencia) |
| WO2009069727A1 (ja) | 2007-11-28 | 2009-06-04 | Fujifilm Corporation | 生体高分子およびポリペプチドの化学修飾方法 |
| WO2012069655A2 (en) | 2010-11-26 | 2012-05-31 | Molecular Partners Ag | Improved n-terminal capping modules for designed ankyrin repeat proteins |
| WO2013123152A2 (en) * | 2012-02-17 | 2013-08-22 | Seattle Genetics, Inc. | ANTIBODIES TO INTEGRIN αVβ6 AND USE OF SAME TO TREAT CANCER |
| EP3131566B1 (en) * | 2014-04-15 | 2022-10-05 | The Regents of the University of California | Bi-terminal pegylated integrin-binding peptides and methods of use thereof |
| WO2016164357A1 (en) | 2015-04-06 | 2016-10-13 | The Board Of Regents Of The University Of Oklahoma | Phages for biomarker capture and methods of use |
| EP3130912B1 (de) | 2015-08-14 | 2017-06-28 | Sick Ag | Verfahren zur bestimmung der konzentration einer gaskomponente und spektrometer dafür |
| JOP20170161A1 (ar) | 2016-08-04 | 2019-01-30 | Arrowhead Pharmaceuticals Inc | عوامل RNAi للعدوى بفيروس التهاب الكبد ب |
| WO2018085415A1 (en) * | 2016-11-01 | 2018-05-11 | Arrowhead Pharmaceuticals, Inc. | Alpha-v beta-6 integrin ligands and uses thereof |
-
2017
- 2017-11-01 WO PCT/US2017/059550 patent/WO2018085415A1/en not_active Ceased
- 2017-11-01 IL IL266343A patent/IL266343B2/en unknown
- 2017-11-01 JO JOP/2019/0084A patent/JOP20190084B1/ar active
- 2017-11-01 SI SI201731066T patent/SI3535397T1/sl unknown
- 2017-11-01 AU AU2017354041A patent/AU2017354041B2/en active Active
- 2017-11-01 CN CN202311057967.9A patent/CN117285626A/zh active Pending
- 2017-11-01 CN CN201780068077.4A patent/CN109952376B/zh active Active
- 2017-11-01 HR HRP20220181TT patent/HRP20220181T1/hr unknown
- 2017-11-01 KR KR1020197012274A patent/KR102634762B1/ko active Active
- 2017-11-01 EP EP21202340.2A patent/EP3981780A1/en active Pending
- 2017-11-01 IL IL305158A patent/IL305158A/en unknown
- 2017-11-01 EP EP17867252.3A patent/EP3535397B1/en active Active
- 2017-11-01 DK DK17867252.3T patent/DK3535397T3/da active
- 2017-11-01 MX MX2019004909A patent/MX2019004909A/es unknown
- 2017-11-01 PL PL17867252T patent/PL3535397T3/pl unknown
- 2017-11-01 JP JP2019522676A patent/JP7291624B2/ja active Active
- 2017-11-01 EA EA201991102A patent/EA201991102A1/ru unknown
- 2017-11-01 TW TW106137824A patent/TWI776821B/zh active
- 2017-11-01 ES ES17867252T patent/ES2906109T3/es active Active
- 2017-11-01 CA CA3039618A patent/CA3039618A1/en active Pending
-
2019
- 2019-03-27 ZA ZA2019/01905A patent/ZA201901905B/en unknown
- 2019-04-26 MX MX2023007046A patent/MX2023007046A/es unknown
- 2019-04-26 MX MX2023007051A patent/MX2023007051A/es unknown
- 2019-04-30 US US16/399,073 patent/US11180529B2/en active Active
- 2019-05-01 SA SA519401709A patent/SA519401709B1/ar unknown
-
2021
- 2021-10-14 US US17/501,486 patent/US12173086B2/en active Active
-
2022
- 2022-03-18 ZA ZA2022/03240A patent/ZA202203240B/en unknown
-
2023
- 2023-06-02 JP JP2023091857A patent/JP2023105046A/ja not_active Withdrawn
-
2024
- 2024-04-24 AU AU2024202695A patent/AU2024202695A1/en active Pending
-
2025
- 2025-05-02 JP JP2025076681A patent/JP2025107348A/ja active Pending